Navigation Links
VerifyNow Aspirin Assay

ProductsVerifyNow Aspirin Assay
Company Accumetrics
Item VerifyNow Aspirin Assay
Features Each single-use disposable assay device, such as the VerifyNow IIb/IIIa or VerifyNow Aspirin Assay, contains all needed reagents to provide analytical results for a specific assay. Assay devices are individually pouched and may be used until the expiration date printed on each kit box and foil pouch.

The assay device consists of the following components:

  • Finger Grip: Each assay device has a handle with which the user can insert or remove the assay device from the assay device port.
  • Staging Well: The blood sample is held in this area for temperature stabilization prior to analysis.
  • Assay Device Spot Code: Each assay device is labeled with a unique spot code. Upon insertion of the assay device into the assay device port, the instrument automatically scans the spot code and determines which assay is being performed, records the lot number, and verifies that the assay device has not expired.
  • Sample Well: The sample well is the area of the assay device where the blood collection tube is inserted. The well contains a Blood Collection Tube Spike for sampling directly from a closed blood collection tube. A protective sheath is removed from the assay device spike before use.
  • Humidity Indicator: Each assay device has a humidity sensor to determine whether the assay device has been exposed to excess humidity.
  • Mixing Chamber/Detection Wells: The wells contain all necessary reagents for the specific assays.
Description Aspirin is the medication most commonly prescribed for the prevention of life threatening vascular events such as heart attacks and strokes. However, a number of studies have shown that as many as 30% of people taking daily aspirin therapy to prevent a recurrent vascular event may not be receiving aspirin's full benefits. These people are at greater risk for a heart attack or stroke.

The VerifyNow Aspirin Assay is a qualitative test to aid in the detection of platelet dysfunction due to aspirin (ASA) ingestion in citrated whole blood for the point of care or laboratory setting.

The VerifyNow System is a turbidimetric based optical detection system which measures platelet induced aggregation as an increase in light transmittance. The system consists of an instrument, a disposable assay device and controls. The assay device contains reagents based on microbead agglutination technology. The assay device contains a lyophilized preparation of human fibrinogen-coated beads, platelet agonist, preservative and buffer. The patient sample is 3.2% citrated whole blood, which is automatically dispensed from the blood collection tube into the assay device by the instrument, with no blood handling required by the user.

Info Accumetrics
Customer Service: (800) 643-1640
Web site: http://www.accumetrics.com

Related medicine products :

1. VerifyNow System
2. VerifyNow IIb/IIIa Assay
3. VerifyNow Clopidogrel Assay
4. VerifyNow (Ultegra) System
5. Uric Acid Enzymatic Assay
6. Lithium Enzymatic Assay Kit
7. Retinol Binding Protein EIA Vitamin Assays 030-6110 RBP Bone and Minearl Metabolism
8. Vitamin B6 Jumbo REA Vitamin Assays, Cardiovascular 001-RK-VB6N
9. Vitamin B6 REA Vitamin Assays, Cardiovascular 001-RK-VB6
10. Procleix HIV-1/HCV Assay
11. VERSANT HIV RNA 3.0 Assay (bDNA)
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
This is a perfect tool for retrieving free floating sections from the Vibratome bath.
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray.
Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi
Medicine Products:
(Date:11/21/2008)...alif., Nov. 21 Album Creative Stud...unches a new program offering big brand marketing ...e large, expensive ad agency process and services,... hands-on approach," says Matt Parker, Creative Di...es experience and proven brand-building techniques...
(Date:11/21/2008)... Fla. -- A Florida State University College of Med...vered an important new layer of regulation in the ... understanding of the way cancer begins. , Wang,...the College of Medicine, said the findings will le...ould lead to the design of new drugs that kill can...
(Date:11/21/2008)...ov. 21 The Providence Se...ed that Craig A. Norris, the Company,s,Chief Oper... Board of,Directors. Mr. Norris, appointment fil... of Steven I. Geringer and returns the board to si...ittee of the Board. , Mr. Norris, age 41, h...
(Date:11/21/2008)...e day lead to a novel technique to combat cancer, ...thDay News) -- Belgian researchers have discovered... sugar for food, and this might lead to new treatm...vive and proliferate, all cells in the body need t...lucose], a process that requires oxygen. Compared ...
Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2
...en suffer from asthma more than any other chronic ...hildren have a greater risk// than others of exper...gency. Previous research has shown that in compa..., African-Americans have a higher rate of asthma, ...
...chers have found that a method of natural family p...ertile phase in a woman’s menstrual// cycle is as ...nplanned pregnancies, according to a report. The ...f natural family planning (NFP) that enables coupl...
...ng is the primary emotion felt after the death of ...o depression being the primary// emotion and the o...arch. The researchers from the Harvard Medical S...cine came about their conclusions while interviewi...
...a remains a dreaded human infection with around 30...rted every year. Controlling this disease// requir...nvolves a study of its basic reproductive number, ...e average number of secondary cases infected by a ...
Other Medicine News:Health News:Race May Play a Role in Children’s Asthma Car 2Health News:Family Planning Method is as Effective as the Contraceptive Pill 2Health News:Family Planning Method is as Effective as the Contraceptive Pill 3Health News:Family Planning Method is as Effective as the Contraceptive Pill 4Health News:Yearning -the Most Intense Emotion in Bereavement 2
(Date:11/20/2008)...mber 20 Arpida (SWX:,AR...Advisory Committee of the,U.S. Food and Drug Admi...proval of intravenous iclaprim, an antibiotic curr...s with complicated skin and skin structure infecti...in-resistant Staphylococcus,aureus (MRSA). , ...
(Date:11/20/2008)... -- Clinical data from a prospective,registry pre...m shows DVT,treatment with the Trellis(R) Periphe...Santa Clara, CA) successfully breaks up the blood ... This technique, called isolated pharmacomechani...y and safely than current catheter-directed thromb...
(Date:11/19/2008)...eve statistical significance , , ISELIN, N....poration (Nasdaq: PARS ) today announced results...anoEmulsion (NE) drug delivery technology formulat...he multi-center, randomized, double-blinded, place...acy of the Company,s 3% Diclofenac Diethanolamine ...
(Date:11/18/2008)...e-FirstCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a ...evelopment Company,and Sosei Group Corporation (...rnational biopharmaceutical company, today announc...al pre-clinical efficacy data for NSL-043/SD118.,...or neuropathic pain and has,successfully complete...
Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Nicotine Plus Alcohol May Be Tough to Beat 5651 1Nicotine Plus Alcohol May Be Tough to Beat 5651 2Nicotine Plus Alcohol May Be Tough to Beat 5651 3AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 1AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 2Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases 771 1Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases 771 2MicroActive Corporation Acquired by Linden and Edgewater 5649 1MicroActive Corporation Acquired by Linden and Edgewater 5649 2
...ies Presented at ECCMID/ICC, MUNICH, Germany, Apri...oday announced results from two studies showing th...l growth in vitro,when tested with a common wettin...ng the activity of oritavancin against S.,pneumoni...ovel,lipoglycopeptide antibiotic, is Targanta,s le...
...rBChE Suppresses Amyloid Plaque,Formation , ANNAPO...ding,biodefense company specializing in the develo...ures against chemical and,biological terrorism, an...utyrylcholinesterase (rBChE) research program were...rence on,Alzheimer,s and Parkinson,s Diseases in S...
Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6